124 related articles for article (PubMed ID: 38885162)
1. Mental Health Trends in Patients With Symptomatic Macromastia After Reduction Mammoplasty.
Park RH; Odega UK; Kilmer LH; Hollenbeck ST; DeGeorge BR
Ann Plast Surg; 2024 Jul; 93(1):30-33. PubMed ID: 38885162
[TBL] [Abstract][Full Text] [Related]
2. Impact of reduction mammoplasty on the quality of life of obese patients suffering from symptomatic macromastia: A descriptive cohort study.
Hernanz F; Fidalgo M; Muñoz P; Noriega MG; Gómez-Fleitas M
J Plast Reconstr Aesthet Surg; 2016 Aug; 69(8):e168-73. PubMed ID: 27344408
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Retrospective Analysis of Complications After Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia: Are These Procedures Equally Safe?
Imahiyerobo TA; Pharmer LA; Swistel AJ; Talmor M
Ann Plast Surg; 2015 Oct; 75(4):370-5. PubMed ID: 24691307
[TBL] [Abstract][Full Text] [Related]
4. Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany.
Jud SM; Brendle-Behnisch A; Hack CC; Preuss C; Arkudas A; Horch RE; Beckmann MW; Lux MP
Arch Gynecol Obstet; 2021 Feb; 303(2):521-531. PubMed ID: 33123809
[TBL] [Abstract][Full Text] [Related]
5. Reduction mammaplasty improves levels of anxiety, depression and body image satisfaction in patients with symptomatic macromastia in the short and long term.
Pérez-Panzano E; Gascón-Catalán A; Sousa-Domínguez R; Carrera-Lasfuentes P; García-Campayo J; Güemes-Sánchez A
J Psychosom Obstet Gynaecol; 2017 Dec; 38(4):268-275. PubMed ID: 28075191
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life Following Symptomatic Macromastia Surgery: Short- and Long-term Evaluation.
Pérez-Panzano E; Güemes-Sánchez A; Gascón-Catalán A
Breast J; 2016 Jul; 22(4):397-406. PubMed ID: 27038061
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Reduction Mammaplasty on Quality of Life in Adolescents With Macromastia.
Nuzzi LC; Firriolo JM; Pike CM; Cerrato FE; Webb ML; Faulkner HR; DiVasta AD; Labow BI
Pediatrics; 2017 Nov; 140(5):. PubMed ID: 28986442
[TBL] [Abstract][Full Text] [Related]
8. Do larger reductions yield larger returns? patient-reported outcomes as a function of specimen weight in bilateral reduction mammoplasty.
Yao A; LaFontaine S; Sultan SM; Rizzo AM; Draper L; Benacquista T; Weichman KE
J Plast Reconstr Aesthet Surg; 2021 Oct; 74(10):2537-2549. PubMed ID: 33893055
[TBL] [Abstract][Full Text] [Related]
9. Early complications of a reduction mammoplasty technique in the treatment of macromastia with or without breast cancer.
Gulcelik MA; Dogan L; Camlibel M; Karaman N; Kuru B; Alagol H; Ozaslan C
Clin Breast Cancer; 2011 Dec; 11(6):395-9. PubMed ID: 21993009
[TBL] [Abstract][Full Text] [Related]
10. Treatment of symptomatic macromastia in a breast unit.
Hernanz F; Santos R; Arruabarrena A; Schneider J; Gómez Fleitas M
World J Surg Oncol; 2010 Nov; 8():93. PubMed ID: 21040550
[TBL] [Abstract][Full Text] [Related]
11. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters.
Sclar DA; Robison LM; Skaer TL; Galin RS
Int J Psychiatry Med; 1998; 28(4):407-19. PubMed ID: 10207740
[TBL] [Abstract][Full Text] [Related]
12. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
Wade RL; Kindermann SL; Hou Q; Thase ME
J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461
[TBL] [Abstract][Full Text] [Related]
14. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Khandker RK; Kruzikas DT; McLaughlin TP
J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
[TBL] [Abstract][Full Text] [Related]
15. Obesity and early complications following reduction mammaplasty: an analysis of 4545 patients from the 2005-2011 NSQIP datasets.
Nelson JA; Fischer JP; Chung CU; West A; Tuggle CT; Serletti JM; Kovach SJ
J Plast Surg Hand Surg; 2014 Oct; 48(5):334-9. PubMed ID: 24506446
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported quality-of-life outcomes of breast reduction evaluated with generic questionnaires and the breast reduction assessed severity scale.
Kececi Y; Sir E; Gungor M
Aesthet Surg J; 2015 Jan; 35(1):48-54. PubMed ID: 25536504
[TBL] [Abstract][Full Text] [Related]
17. The importance of preoperative imaging methods in reduction mammoplasty.
Derebaşınlıoğlu H; Karaca SN
J Plast Reconstr Aesthet Surg; 2022 Apr; 75(4):1424-1430. PubMed ID: 34949572
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life and Alleviation of Symptoms After Breast Reduction for Macromastia in Obese Patients: Is Surgery Worth It?
Güemes A; Pérez E; Sousa R; Gil I; Valcarreres MP; Carrera P; Gracia MD; Artigas L; Gascon A
Aesthetic Plast Surg; 2016 Feb; 40(1):62-70. PubMed ID: 26718700
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.
Vlahiotis A; Devine ST; Eichholz J; Kautzner A
J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545
[TBL] [Abstract][Full Text] [Related]
20. The Central Mound Pedicle: A Safe and Effective Technique for Reduction Mammaplasty.
DeLong MR; Chang I; Farajzadeh M; Nahabet EH; Roostaeian J; Festekjian J; Rough J; Da Lio AL
Plast Reconstr Surg; 2020 Oct; 146(4):725-733. PubMed ID: 32590526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
